Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ULVAC-PHI is a Japan-based manufacturer of ultra-high-vacuum surface analysis instruments used in research, development, and quality control across semiconductors, batteries, advanced materials, and selected biomedical applications. The company designs, manufactures, sells, and supports analytical systems including XPS, AES, TOF-SIMS, D-SIMS, and HAXPES platforms, along with related software, training, and analytical services. ULVAC-PHI operates as a subsidiary of ULVAC and works globally through affiliated PHI/Physical Electronics organizations, including Physical Electronics USA. While it is not a therapeutics developer, it is relevant to life sciences and healthcare as a provider of analytical instrumentation used in biomaterials and biomedical surface characterization. Its business is best characterized as a commercial instrumentation and platform company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ULVAC-PHI.